TSXV: RLV ● FRA: 6BXMarch 2, 2018

DISCLAIMERTHIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM TECHNOLOGIES INC. (THE “COMPANY”) SOLELY FOR INFORMATION PURPOSES. THISDOCUMENT DOES NOT CONSTITUTE AN OFFERING DOCUMENT. THIS DOCUMENT IS THE SOLE RESPONSIBILITY OF THE COMPANY. INFORMATIONCONTAINED HEREIN DOES NOT PURPORT TO BE COMPLETE AND IS SUBJECT TO CERTAIN QUALIFICATIONS AND ASSUMPTIONS AND SHOULD NOTBE RELIED UPON FOR THE PURPOSE OF MAKING AN INVESTMENT IN THE COMPANY’S SECURITIES OR ENTERING INTO ANY TRANSACTION INRELATION THEREWITH. THE INFORMATION AND OPINIONS CONTAINED IN THIS DOCUMENT ARE PROVIDED AS AT THE DATE HEREOF AND ARESUBJECT TO CHANGE WITHOUT NOTICE AND, IN FURNISHING THIS DOCUMENT, THE COMPANY DOES NOT UNDERTAKE OR AGREE TO ANYOBLIGATION TO PROVIDE RECIPIENTS WITH ACCESS TO ANY ADDITIONAL INFORMATION OR TO UPDATE OR CORRECT THE DOCUMENT. THISDOCUMENT, NOR HAS IT REVIEWED THIS DOCUMENT.

FORWARD LOOKING INFORMATIONCERTAIN OF THE INFORMATION CONTAINED IN THIS PRESENTATION MAY CONTAIN “FORWARD-LOOKING INFORMATION”. FORWARD-LOOKINGINFORMATION AND STATEMENTS MAY INCLUDE, AMONG OTHERS, STATEMENTS REGARDING THE FUTURE PLANS, COSTS, OBJECTIVES ORPERFORMANCE OF THE COMPANY, OR THE ASSUMPTIONS UNDERLYING ANY OF THE FOREGOING. IN THIS PRESENTATION, WORDS SUCH AS“MAY”, “WOULD”, “COULD”, “WILL”, “LIKELY”, “BELIEVE”, “EXPECT”, “ANTICIPATE”, “INTEND”, “PLAN”, “ESTIMATE” AND SIMILAR WORDS AND THENEGATIVE FORM THEREOF ARE USED TO IDENTIFY FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS SHOULD NOT BE READAS GUARANTEES OF FUTURE PERFORMANCE OR RESULTS, AND WILL NOT NECESSARILY BE ACCURATE INDICATIONS OF WHETHER, OR THE TIMESAT OR BY WHICH, SUCH FUTURE PERFORMANCE WILL BE ACHIEVED. FORWARD-LOOKING STATEMENTS AND INFORMATION ARE BASED ONINFORMATION AVAILABLE AT THE TIME AND/OR MANAGEMENT’S GOOD-FAITH BELIEF WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TOKNOWN OR UNKNOWN RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER UNPREDICTABLE FACTORS, MANY OF WHICH ARE BEYOND THECOMPANY’S CONTROL. THE COMPANY DOES NOT INTEND, NOR DOES THE COMPANY UNDERTAKE ANY OBLIGATION, TO UPDATE OR REVISE ANYFORWARD-LOOKING INFORMATION OR STATEMENTS CONTAINED IN THIS PRESENTATION TO REFLECT SUBSEQUENT INFORMATION, EVENTS ORCIRCUMSTANCES OR OTHERWISE, EXCEPT IF REQUIRED BY APPLICABLE LAWS.

TSXV:RLV ● FRA:6BX

WHO WE ARE

3

WE ARE a Brand Acquisition Company

WE FOCUS on Health & Wellness

WE PREFER E-Commerce Brands

TSXV:RLV ● FRA:6BX

HOW WE CREATE VALUE

4

WE Acquire E-Brands at 4X EBIT

WE Build Brand Equity (Marketing & New Products)

WE Leverage Great People and Technology

TSXV:RLV ● FRA:6BX 5

Andre Godin - Chairman• EVP & CFO, IntelGenx Corp• Biotech and Pharma• Strength: Finance & Strategy

Pierre Bertrand - Director• CEO, Essilor Canada• Biotech, Pharma and Consumer Products• Strength: Mergers & Acquisitions

Tina Sampalis, - Director• President, Vanguard

Strategic Consulting • Medicine, Biotech and Pharma• Strength: Product Development

Michel Timperio - Director• VP Strategic Development, Neptune

Technologies • Biotech and Pharma• Strength: Business Development

LEADERSHIP

Aurelio Useche – CEO • Green-tech, Technology and

Natural Resources and • Strength: Strategy and

Operations Management

TSXV:RLV ● FRA:6BX

SOLID MARKETPLACE

6

Source: http://www.businessinsider.com/e-commerce-disrupting-health-and-personal-care-market-2015-4

HEALTH AND WELLNESS MARKET

ü A Worldwide $3.7 Trillion Industry

ü Less than 10% of sales online vs. 20-30% in other segments

ü Online Business Estimated to grow 17% per year

TSXV:RLV ● FRA:6BX

RLV ACQUISITION STRATEGY

7

PROFILE AND RISK

ü Brands with revenues between $2M - $20M

ü Average 4X EBIT

ü Shared Transaction Risk

STRATEGIC OUTCOME

ü Accrete Talent

ü Build Brand Awareness across platforms & geographies

ü Drive efficiencies through economies of scale

TSXV:RLV ● FRA:6BX 8

HEALTH & WELLNESS

Supplements

Mind and Body

Nutrition

Natural Health

Skin Care

RLV BRAND STRATEGY

Active Life

TSXV:RLV ● FRA:6BX

RLV TODAY

9

OPERATING PLATFORMwww.bioganix.com

EXCLUSIVE PARTNERSHempco, Tersus, Phyto

MARKETING MACHINEAutomationArtificial IntelligenceNew Technology B/C

BUILD BRAND EQUITYRebrandRepositionExpand

FINANCIAL POSITION

1. TRIPLED MARKET CAP

2. STRONGER BALANCE SHEET

3. CASH POSITIVE ASSET

4. EXCELLENT LIQUIDITY

5. INNOVATION FINANCE

TSXV:RLV ● FRA:6BX 10

2017 Milestones

JULY AUGUST SEPTEMBER OCTOBER

MARKET GUIDANCEBGX SPORT

CONTROLOFBIOGANIX

PET BRANDAI BIG DATA

NOVEMBER DECEMBER

ABIS HEMPCO PROVINAL

TSXV:RLV ● FRA:6BX 11

2018 Plan Timeline

JAN FEB MAR APR

REBRAND GUIDANCESETTING

THE STAGE FOR JV

LAUNCH OF:HEMPOMEGA 7BGX GOLDCURALOE

MAY JUN

JV FINANCE STRATEGICPARTNERS

SECOND WAVE NEW PRODUCTS

EYE ON NEXT ACQUISITION

TSXV:RLV ● FRA:6BX

M&A PIPELINE

12

PIPELINE DETAILS

§ Supports Roll-Up Strategy

§ Average EBIT of 31%

§ Acquisition Multiple 4.4 (Avg)

TSXV:RLV ● FRA:6BX

MARKET COMPARABLES

13

TSXV:RLV ● FRA:6BX

CORPORATE PROFILE

14

GENERAL INFORMATIONSector: Consumer HealthcareTSX Venture: “RLV-V”OTCQB: “RLLVF” Frankfurt: “6BX”Headquarters: Montreal

TRADING INFORMATIONPrice: $0.19

Market Cap: $17MAVG Volume: 700K shares

52-week: $0.085-0.35

CAPITAL STRUCTUREShares O/S: 87MOptions (@0.168): 4.4MWarrants (@0.148): 31M Shares F/D: 122M

KEY HOLDINGSInsiders: 15% Escrowed: 5%

Free Trading: 80%

TSXV: RLV